Aug 11, 2009
With New Patent Infringement Filing, Abbott Escalates Drug War With J&J Subsidiary
In the latest strike in the war between Abbott Biotech and Centocor Ortho Biotech, Abbott has filed a complaint in federal district court claiming that Centocor’s psoriasis drug Stelera infringes an Abbott patent on a human antibody critical to the treatment of some autoimmune disorders. Centocor recently won the biggest patent infringement verdict in U.S. history against Abbott in a suit alleging that Abbott’s blockbuster rheumatoid arthritis drug, Humira, infringes a patent co-owned by Centocor.